We demonstrated that high expression of MCL1 with low expression of BCL-XL and BCL-2 was common in SCLC specimens from clinical patients, and S63845 was effective in high MCL1 with low BCL-XL SCLC cell lines. Here, MCL1 is linked to small cell lung carcinoma.